Cipla Ltd had earlier announced that the Goa manufacturing facility's inspection was conducted from 16-27 September 2019 by the United States Food and Drug Administration (USFDA) and the Company has received a Warning Letter from USFDA. The Company remains committed to maintain the highest standards of compliance and will work closely with the agency to comprehensively address all the observations.
Shares of CIPLA LTD. was last trading in BSE at Rs.424.8 as compared to the previous close of Rs. 430.3. The total number of shares traded during the day was 127033 in over 2718 trades.
The stock hit an intraday high of Rs. 432.1 and intraday low of 420. The net turnover during the day was Rs. 54027782.